Abraham Scaria – Biography
Last update: March 13, 2026Executive profile
Abraham was Vice President and Head of Ophthalmology at Casebia Therapeutics, and Head of Gene Therapy Research at Genzyme.
Abraham Scaria is currentlyChief Science Officer at Beacon Therapeutics - View - Beacon Therapeutics org chart
Create your alert
to follow the career of Abraham Scaria.
Education
Abraham Scaria has a Master of Science in Medical Biochemistry from University of Mumbai and a PhD in Molecular Biology from Indiana University School of Medicine.
They have also studied at University of Mumbai :
Find more alumni from University of Mumbai
They have also studied at Indiana University School of Medicine :
- Mike Frye - Munson Healthcare
- Elizabeth Garofalo - Acadia Pharmaceuticals
- Guy Hudson - Northern Light Health
Find more alumni from Indiana University School of Medicine
More about Abraham Scaria
Selected links
Do you need to know more about Abraham Scaria? More results.
Participate
Social media
- Abraham Scaria on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Abraham Scaria
The colleagues of Abraham Scaria
Company Colleagues
- At Beacon Therapeutics, Abraham Scaria has 16 colleagues including Lance Baldo (CEO), Dave Fellow (Chairman of the Board)…
Industry Colleagues
- In the Biotechnology industry, Abraham Scaria has 35,756 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Abraham Scaria.
Get in Touch
Here are a few tips for establishing great contacts.
